NCT06521684View on ClinicalTrials.gov

Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma

Not yet recruitingOBSERVATIONAL

Enrollment

110

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2025

Conditions

Endometrial NeoplasmsTP53 Gene MutationChromosomal InstabilityMicrosatellite Stable Endometrial Carcinoma

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER